Navigation Links
National University Hospital Singapore Operates on Asia's 1st TRAM Flap Patient Using TIGR® Matrix Surgical Mesh, the World's 1st Long-Term Resorbable Mesh
Date:10/25/2010

SINGAPORE, Oct. 25 /PRNewswire/ -- Singapore company Novus Scientific Pte. Ltd today announced that the National University Hospital (NUH), Singapore has operated on the first patient in its groundbreaking study: Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap - Comparison of TIGR® Matrix (100% Resorbable) vs Polypropylene (Permanent) Mesh.This randomized study, involving 86 patients, received DSRB approval on 9th September 2010. There are plans to expand this to a multi-centre study involving other hospitals in Singapore and in the U.S. TIGR® Matrix Surgical Mesh is the World's 1st Long-Term Resorbable Synthetic Mesh, and it received 510(k) clearance from the US Food and Drug Administration (FDA) in February 2010 for use in reinforcement of soft tissues where weakness exists. TIGR® Matrix Surgical Mesh was launched for sale in the U.S. in June 2010.

"TIGR® Matrix feels soft and conforms well to the surgical site. If the follow up results are good, this will be beneficial to many patients undergoing TRAM Flap procedures, as strong native tissue will replace the mesh over time. This was not possible with permanent synthetic meshes -- we will be monitoring the patient closely during follow up" - Dr. Wei Chen Ong (Consultant) & Dr. Jane Lim (Senior Consultant), Division of Plastic, Reconstructive & Aesthetic Surgery, National University Hospital, Singapore / Study Investigators, TIGR® Matrix Clinical Trial."We're pleased to get our 1st randomized patient included in this study. If the results are promising, we see a number of other potential applications for TIGR® Matrix besides TRAM Flap donor sites; it will be interesting to explore these areas when our surgeons gain more clinical experience and more study data is accrued"- Associate Professor Thiam Chye Lim, Principal Investigator & Head of Division of Plastic, Reconstructive and  Aesthetic Surgery, National University Hospital, Singapore.TIGR® Matrix Surgical Mesh is knitted from two different synthetic resorbable fibers that degrade at different rates following implantation. It is designed to be mechanically strong and supportive of tissue growth for over 6 months and resorbs completely over time, leaving no foreign material behind.

"When we identified a clinical need for this product, we knew that we had the ability and development background to give birth to a product like no other," said Thomas Engstrom, CEO & President of Novus Scientific. "TIGR® Matrix is designed to be strong when you need it and gone when you don't. It is very satisfying to see the product being adopted so enthusiastically by the surgical community. These are exciting times for Novus Scientific!"

About Novus ScientificNovus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices.  Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden.
The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States.

TIGR® is a registered trademark of Novus Scientific Pte. LtdCONTACT:  Tac-Whei Ong+65-9179-6661Novus Scientific Pte. Ltd
'/>"/>

SOURCE Novus Scientific Pte. Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL International to Present at Oppenheimer Healthcare Conference and Morningstar Annual Stocks Forum
2. Purdue Pharma L.P. and the National Community Pharmacists Association Join Forces to Help Prevent Pharmacy Burglary
3. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
4. Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing
5. Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
6. Rhythmlink International Announces Change in Engineering Management
7. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
8. CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at The Marijuana Conference in New York City on Oct. 25 & 26
9. RxDrugSAFE™ Featured in National Campaign by Purdue Pharma and NCPA
10. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
11. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... -- Global Cervical Dysplasia Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/7/2016)... -- Research and Markets has announced the addition of ... Forecast to 2021" report to their offering. ... , , The immunohistochemistry ... at a CAGR of 7.3% during the forecast period of 2016 to ... and rapidly increasing geriatric population across the globe are the primary driving ...
(Date:12/7/2016)... , Dec. 7, 2016  Palatin Technologies, Inc. ... closed on a previously disclosed underwritten public offering ... Genuity acted as sole book-running manager, Roth Capital ... Markets acted as co-manager for the offering. ... million in net proceeds, allowing us to continue ...
Breaking Medicine Technology:
(Date:12/7/2016)... New York, NY (PRWEB) , ... December 07, ... ... measurable amounts of the drug in their bodies, a researcher at the Icahn ... the journal Pediatric Research. , The study found that when young children are ...
(Date:12/7/2016)... LAKE CITY, UTAH (PRWEB) , ... December 07, ... ... productivity, today announced the release of Smart Device Remote Control through a new ... management across all platforms and strengthens its mobile solutions to help businesses maximize ...
(Date:12/7/2016)... ... December 07, 2016 , ... EnghouseSystems ... purchase price of approximately $17.4 million (net of the cash acquired), subject ... $13.2 million. Headquartered in Barcelona, Spain, Presence is a leading provider of ...
(Date:12/7/2016)... , ... December 07, 2016 , ... It is vital ... is with useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, ... 'need for speed' and the need to operate in a GLP (Good Laboratory Practice) ...
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward Hallowell, ... on social media that offer a rare glimpse into the mind of those people ... New York Times bestselling author, has described people with ADHD as having “Ferrari engines ...
Breaking Medicine News(10 mins):